In Guska, we developed synthetic RNA oncolytic virus therapies designed to deliver potent and safe immunostimulatory effects. By precisely targeting and eliminating cancer cells while preserving healthy tissue, our innovative approach offers a more effective and less harmful alternative to traditional treatments. Beyond direct cancer targeting, our therapies stimulate a robust immune response, empowering the body to fight tumors more effectively and paving the way for improved patient outcomes.